<?xml version="1.0" encoding="UTF-8"?>
<p>We then applied the bait panel to two clinical cohorts; one from Sri Lanka and another from Singapore. The first cohort was collected as a laboratory-based enhanced sentinel surveillance system in the Colombo District of Sri Lanka from 2012â€“2014 [
 <xref rid="pntd.0007184.ref028" ref-type="bibr">28</xref>]. This collection period coincided with a severe dengue epidemic predominantly (~80%) driven by DENV1 with a smaller number (~20%) of cases due to DENV4 [
 <xref rid="pntd.0007184.ref028" ref-type="bibr">28</xref>,
 <xref rid="pntd.0007184.ref037" ref-type="bibr">37</xref>,
 <xref rid="pntd.0007184.ref038" ref-type="bibr">38</xref>]. From this collection, we utilized our enrichment platform to obtain full or nearly full genome sequences for 143 DENV1 and 27 DENV4 isolates (
 <bold>
  <xref ref-type="supplementary-material" rid="pntd.0007184.s002">S2 Fig</xref>
 </bold>). The second cohort of 162 samples was collected from August to September 2016 as part of a national response effort to the first outbreak of ZIKV in Singapore (
 <bold>
  <xref ref-type="supplementary-material" rid="pntd.0007184.s002">S2 Fig</xref>
 </bold>) [
 <xref rid="pntd.0007184.ref027" ref-type="bibr">27</xref>,
 <xref rid="pntd.0007184.ref039" ref-type="bibr">39</xref>]. During the course of our investigation, we were also able to detect one dual infection in the Singaporean cohort where we were able to recover both DENV3 and ZIKV from the same patient (
 <bold>
  <xref ref-type="fig" rid="pntd.0007184.g004">Fig 4</xref>
 </bold>).
</p>
